<DOC>
	<DOCNO>NCT01100736</DOCNO>
	<brief_summary>Endothelin-1 ( ET-1 ) link number condition include pulmonary arterial hypertension ( PAH ) . ET-1 act via 2 receptor , ETA ETB . The ET-1 receptor blocker bosentan sitaxsentan show beneficial patient PAH . Bosentan block ETA ETB receptor . Sitaxsentan selectively block ETA receptor . Theoretically , selective ETA blockade may associate great vasodilation clearance ET-1 leave ETB receptor unblock . This directly study human . We aim investigate endothelial ETB-mediated vascular response bosentan sitaxsentan use ETB selective agonist ( ET-3 ) . We hypothesise clinically relevant dos : - Bosentan show evidence ETB receptor blockade compare sitaxsentan placebo . - These effect confirm 2 functional marker ETB receptor antagonism : plasma ET-1 ( sensitive , necessarily clinically relevant marker ) , forearm vasodilator response ET-3 .</brief_summary>
	<brief_title>Role Endothelin-A ( ETA ) Endothelin-B ( ETB ) Receptors Vasodilatory Response Endothelin-3 ( ET-3 )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Bosentan</mesh_term>
	<mesh_term>Sitaxsentan</mesh_term>
	<criteria>Healthy men postmenopausal woman Age 1870 year BMI 1835 kg/m2 Are mentally legally incapacitate Have donate blood within last 4 week Have history past present drug alcohol abuse Have participate another clinical trial within 1 month Are consider high risk HIV Hepatitis B Are take routine medicine Are woman take hormone replacement therapy Have significant medical psychiatric illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Forearm Blood Flow</keyword>
	<keyword>Vasodilation</keyword>
	<keyword>Vasoconstriction</keyword>
	<keyword>Endothelin System</keyword>
	<keyword>Endothelin-1</keyword>
	<keyword>Endothelin-3</keyword>
	<keyword>Endothelin antagonist</keyword>
	<keyword>Bosentan</keyword>
	<keyword>Sitaxsentan</keyword>
	<keyword>Endothelin</keyword>
	<keyword>Regional Blood Flow</keyword>
</DOC>